|
|
Volumn 9, Issue 1, 2001, Pages 7-11
|
|
LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival
a
|
|
Author keywords
Allograft; ICAM 1, LFA 1; Idarubicin; Immunoconjugates; Monoclonal antibody
|
|
Indexed keywords
ANTIBODY CONJUGATE;
IDARUBICIN MONOCLONAL ANTIBODY CONJUGATE;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTIBODY;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD3;
MONOCLONAL ANTIBODY CD8;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG FORMULATION;
DRUG POTENTIATION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNE RESPONSE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
DRUG EVALUATION, PRECLINICAL;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IDARUBICIN;
IMMUNE TOLERANCE;
IMMUNOCONJUGATES;
IMMUNOSUPPRESSIVE AGENTS;
INTERCELLULAR ADHESION MOLECULE-1;
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
MICE, INBRED CBA;
SKIN TRANSPLANTATION;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0034784741
PISSN: 09663274
EISSN: None
Source Type: Journal
DOI: 10.1016/S0966-3274(01)00038-7 Document Type: Article |
|
Times cited : (3)
|
|
References (8)
|
